85. Idiopathic interstitial pneumonia Clinical trials / Disease details
Clinical trials : 598 / Drugs : 435 - (DrugBank : 116) / Drug target genes : 100 - Drug target pathways : 210
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR-OOC-15005840 | 2015-01-01 | 2015-01-17 | The significance in prevention of acute exacerbations of IPF by oral administration of eight anabacteria | An observational study of the significance in prevention of acute exacerbations of IPF by oral administration of eight anabacteria | Idiopathic pulmonary fibrosis | The immune-based treatment group :oral Broncho-Vaxom ;no immunotherapeutic group :no immunomodulator treatment ; | Shanghai Pulmonary Hospital | NULL | Recruiting | 50 | 80 | Both | The immune-based treatment group :60;no immunotherapeutic group :60; | China |